Teva Pharmaceutical Industries

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TEVA and other ETFs, options, and stocks.

About TEVA

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. 

CEO
Richard Francis
CEORichard Francis
Employees
33,346
Employees33,346
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
1901
Founded1901
Employees
33,346
Employees33,346

TEVA Key Statistics

Market cap
46.58B
Market cap46.58B
Price-Earnings ratio
90.75
Price-Earnings ratio90.75
Dividend yield
—
Dividend yield—
Average volume
7.71M
Average volume7.71M
High today
$39.83
High today$39.83
Low today
$38.30
Low today$38.30
Open price
$38.35
Open price$38.35
Volume
3.95M
Volume3.95M
52 Week high
$44.57
52 Week high$44.57
52 Week low
$26.00
52 Week low$26.00

Stock Snapshot

Teva Pharmaceutical Industries(TEVA) stock is priced at $39.70, giving the company a market capitalization of 46.58B. It carries a P/E multiple of 90.75.

On 2026-11-20, Teva Pharmaceutical Industries(TEVA) stock moved within a range of $38.30 to $39.83. With shares now at $39.70, the stock is trading +3.7% above its intraday low and -0.3% below the session's peak.

Trading activity shows a volume of 3.95M, compared to an average daily volume of 7.71M.

Over the past 52 weeks, Teva Pharmaceutical Industries(TEVA) stock has traded between a high of $44.57 and a low of $26.00.

Over the past 52 weeks, Teva Pharmaceutical Industries(TEVA) stock has traded between a high of $44.57 and a low of $26.00.

TEVA News

Simply Wall St 3d
Teva Pharmaceutical Industries Could Be 13% Undervalued Following FDA Approval For IGALMI

Teva Pharmaceutical Industries (NYSE:TEVA) just secured U.S. FDA approval for at-home use of IGALMI sublingual film, the first treatment cleared for self-admini...

Teva Pharmaceutical Industries Could Be 13% Undervalued Following FDA Approval For IGALMI

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own TEVA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.